NeoTYPE?? Sounds like Caris Target Now to me (and that sucks). Sanger Sequencing the gold standard?? Its an old technology. There's already NextGen Sequencing and the next generation after that is already being worked on. 49% Revenue growth?? Net Income of $551,000, or $0.01 per share, vs. a loss of $(293,000), or ($0.01) per share in Q2 2011. Hey this is impressive, NOT